Table 2.
Distribution of benign USFNA MTNS+ scores and their associated surgical pathology diagnosis
MTNS | Total (n) | Benign n (%) | Malignant n (%) |
---|---|---|---|
1 | 1 | 1 (1.0) | 0 (0.0) |
2 | 1 | 1 (1.0) | 0 (0.0) |
3 | 0 | 0 (0.0) | 0 (0.0) |
4 | 9 | 9 (8.9) | 0 (0.0) |
5 | 21 | 20 (19.8) | 1 (1.0) |
6 | 14 | 13 (12.9) | 1 (1.0) |
7 | 20 | 15 (14.9) | 5 (5.0) |
8 | 17 | 12 (11.9) | 5 (5.0) |
9 | 7 | 5 (5.0) | 2 (2.0) |
10 | 7 | 6 (5.9) | 1 (1.0) |
11 | 2 | 2 (2.0) | 0 (0.0) |
12 | 0 | 0 (0.0) | 0 (0.0) |
13 | 1 | 1 (1.0) | 0 (0.0) |
14 | 0 | 0 (0.0) | 0 (0.0) |
15 | 0 | 0 (0.0) | 0 (0.0) |
16 | 0 | 0 (0.0) | 0 (0.0) |
17 | 0 | 0 (0.0) | 0 (0.0) |
18 | 1 | 0 (0.0) | 1 (1.0) |
Total | 101 | 85 (84.2) | 16 (15.8) |
MTNS+ McGill Thyroid Nodule Score Plus. USFNA Ultrasound guided fine needle aspiration